cagrisema cagrilintide semaglutide phase 3 results 2024 2025 Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, study Novo Nordisk's CagriSema outperforms Ozempic

These drugs have gained enormous attention in recent years because of their effectiveness in treating obesity

What This Means for Patients For individuals with both type 2 diabetes and CKD, Ozempic offers an important new treatment option to help protect kidney function and reduce cardiovascular risks

seek medical advice for symptoms such as right upper abdominal pain, fever or jaundice Thyroid concerns report any neck mass, hoarseness, difficulty swallowing or breathing (based on findings in rodent studies, though relevance to humans is uncertain) [15] [4] Acute kidney injury adequate hydration is important, especially during gastrointestinal upset Important safety information: Ozempic is not recommended during pregnancy or breastfeeding Women of childbearing potential should stop Ozempic at least 2 months before a planned pregnancy [4] Ozempic is not indicated for type 1 diabetes or diabetic ketoacidosis After first use, Ozempic pens can be stored for 6 weeks either below 30C or in a refrigerator (2C to 8C)

To be on the safe side, it should be discussed with a doctor or another clinician

These are skills that matter

doi: 10.1530/EJE-13-0060 6 Espinosa-de-los-MonterosALSosaEMartinezNMercadoM